Studies on the pharmacology of α-methyl-3,4-dihydroxyphenylalanine (α-methyl-DOPA) and α-methylnorepinephrine Part II
- 30 November 1967
- journal article
- research article
- Published by Elsevier in International Journal of Neuropharmacology
- Vol. 6 (6), 453-IN9
- https://doi.org/10.1016/0028-3908(67)90045-7
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Failure of Reserpine to Deplete Noradrenaline Neurons of α-Methylnoradrenaline Formed from α-Methyl DOPAActa Pharmacologica et Toxicologica, 1965
- Die Wirkung des α-Methyldopa auf die Aufnahme und den Stoffwechsel von markiertem NoradrenalinNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1964
- Behavioural Stimulation due to Alpha-methyl Meta-tyrosineNature, 1963
- Awakening from Reserpine Sedation by α-MethyldopaJournal of Pharmacy and Pharmacology, 1963
- A new inhibitor of decarboxylase of aromatic amino acidsCellular and Molecular Life Sciences, 1962
- METHYLDOPA IN THE TREATMENT OF HYPERTENSIONThe Lancet, 1962
- METHYLDOPA IN HYPERTENSION CLINICAL AND PHARMACOLOGICAL STUDIESThe Lancet, 1962
- In‐Vivo Decarboxylation of α‐Methyl DOPA and α‐Methyl MetatyrosineActa Physiologica Scandinavica, 1962
- On the distribution in brain of monoamines and of enzymes responsible for their formationCellular and Molecular Life Sciences, 1959
- MODIFICATION BY DRUGS OF PERFORMANCE ON SIMPLE SCHEDULES OF POSITIVE REINFORCEMENTAnnals of the New York Academy of Sciences, 1956